What have been the results of GW Pharmaceuticals clinical trials to date?
To date GW has completed four randomised, double-blind, placebo-controlled Phase III trials which involved approximately 350 patients suffering from Multiple Sclerosis and neuropathic pain. Each of the four trials reported positive data, including statistically significant reductions in neuropathic pain, spasticity and sleep disturbance. For further information please see Phase III Clinical Trials.
